As per the latest report by IMARC Group, titled “Bio-Implants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the global bio-implants market size reached US$ 117.1 Billion in 2022. Bio-implants are bioengineered products that are utilized to replace, support, enhance or regularize physiological functions. They are made from biosynthetic materials such as collagen and tissue-engineered products like artificial skin or tissues. They are divided into three categories, namely, biological implants that comprise cell therapy, bioartificial organs and tissue engineering; biologized implants which include in-vivo cell lining, technical implants and biohybrid systems; and biofunctionalized implants that include surface-functionalized implants and drug-eluting stents.
Global Bio-Implants Market Trends:
Owing to sedentary lifestyles, altering consumption patterns and inadequate nutritional intake among individuals, the prevalence of chronic conditions, such as osteoarthritis, and neuropathic, congenital and cardiovascular diseases, has increased which, in turn, is augmenting the demand for bio-implants worldwide. In addition, the geriatric population represents the biggest end user of bio-implants as elderly individuals are relatively more susceptible to coronary heart diseases, peripheral artery diseases and other age-related conditions. Apart from this, manufacturers are developing innovative prosthetics to reduce production costs and offer customized devices to patients. Further, due to the increasing beauty consciousness, along with the improving success rate of cosmetic surgeries, there has been a rise in the number of individuals seeking bio-implants for enhancing their physical appearance. Looking forward, the market is projected to reach a value of US$ 189.0 Billion by 2028, expanding at a CAGR of
8.12% during 2023-2028.
- Based on the type, the market has been divided into cardiovascular, dental, spinal, orthopaedic, ophthalmic and other implants. Currently, orthopaedic implants represent the most popular product type due to the rising cases of cardiovascular diseases.
- On the basis of the material, the market has been segmented into metallic, ceramic, polymer and biological.
- The market has been segregated on the basis of the origin into allograft, autograft, xenograft and synthetic. At present, xenograft exhibits a clear dominance in the market.
- Based on the mode of administration, the market has been categorized into surgical and non surgical.
- On the basis of the end user, the market has been classified into ambulatory surgical centers, clinics, hospitals and others. Amongst these, hospitals represent the biggest end user of bio-implants.
- Region-wise, the market has been segregated into Europe, Asia Pacific, North America, Latin America, and Middle East and Asia. Presently, North America is the leading market, holding majority of the market share.
- The competitive landscape of the market has also been examined with some of the key players being Abbott Laboratories, Boston Scientific Corporation, Stryker Corporation, St. Jude Medical Inc., Medtronic Inc., Smith and Nephew, Wright Medical Group, Zimmer Biomet, Dentsply Sirona, Invibio Limited, Straumann, Danaher Corporation, Cardinal Health, Johnson & Johnson, B. Braun Melsungen, LifeNet Health, Inc and Endo International plc.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Follow us on twitter: @imarcglobal